SCORAD_guideline v.1
SCORAD provides a standardised model for assessing the severity of atopic dermatitis lesions.
To provide a standardised model for assessing the severity of atopic dermatitis lesions.
The eczema affected area section refers to the extent of body surface area affected: Head and neck (up to 9%); Upper extremities (up to 18% each); Anterior trunk (up to 18%); Back (up to 18%); Lower extremities (up to 18% each); Genitals (up to 1%). The intensity section consists in six clinical signs that assess the intensity of the condition: Redness; Swelling; Oozing / Crusting; Scratch marks; Skin thickening (excoriations, lichenification); Dryness (independent of any inflammation present). Each of the signs is awarded a number of points, dependent on their perceived severity, on the following scale: None (0); Mild (1); Moderate (2); Severe (3). The subjective symptoms section consists in 2 items: Prurit (itch); Insomnia (sleeplessness). These two are evaluated (by patient or a relative) based on quality of life in the three days before the evaluation. A visual analogue scale is used, with 0 for no symptoms and 10, most severe symptoms. To compute the SCORAD result, use the following formula: SCORAD = Affected area score / 5 + 7 x Intensity score / 2 + Subjective symptoms score
Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23-31. doi: 10.1159/000247298. PMID: 8435513.
OBSERVATION.scorad.v0, EVALUATION.scorad_assessment.v0
